The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling

International Journal of Biochemistry and Cell Biology

Volumn 69, Issue , 2015, Pages 153-161

  Mao, Rurong ^a   Zou, Fangyuan ^a   Yang, Liyan ^a   Lin, Shengchao ^a   Li, Yueqi ^a   Ma, Mingxing ^a   Yin, Peihao ^b   Liang, Xin ^a   Liu, Jianwen ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

CAC; IGF 1R; MiR 139 5p; Transgenic murine model; Catenin

Indexed keywords

BETA CATENIN; DOCUSATE SODIUM; MICRORNA; MICRORNA 139 5P; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG; WNT PROTEIN; DEXTRAN SULFATE; MIRN139 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL NUCLEUS; CELL PROLIFERATION; COLITIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; GENE LOSS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HCT116 CELL LINE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; COLON; COLON TUMOR; DISEASE COURSE; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; WNT SIGNALING PATHWAY;

ANIMALS; CARCINOGENESIS; COLITIS; COLON; COLONIC NEOPLASMS; DEXTRAN SULFATE; DISEASE PROGRESSION; GENE EXPRESSION; HCT116 CELLS; HUMANS; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84946208344     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2015.10.008     Document Type: Article

References (48)

1. F.J. Abdul Khalek, G.I. Gallicano, and L. Mishra Colon cancer stem cells Gastrointest. Cancer Res.: GCR 2010 S16 S23
2. H. Aberle, A. Bauer, J. Stappert, A. Kispert, and R. Kemler Beta-catenin is a target for the ubiquitin-proteasome pathway EMBO J. 16 1997 3797 3804
3. M. Abu-Remaileh, S. Bender, G. Raddatz, I. Ansari, D. Cohen, J. Gutekunst, and et al. Chronic inflammation induces a novel epigenetic program that is conserved in intestinal adenomas and in colorectal cancer Cancer Res. 75 2015 2120 2130
4. A.G. Bader, S. Kang, L. Zhao, and P.K. Vogt Oncogenic PI3K deregulates transcription and translation Nat. Rev. Cancer 5 2005 921 929
5. W. Bao, H.J. Fu, Q.S. Xie, L. Wang, R. Zhang, Z.Y. Guo, and et al. HER2 interacts with CD44 to up-regulate CXCR4 via epigenetic silencing of microRNA-139 in gastric cancer cells Gastroenterology 141 2011 2076-87 e6
6. L. Beaugerie, M. Svrcek, P. Seksik, A.M. Bouvier, T. Simon, M. Allez, and et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease Gastroenterology 145 2013 166-75 e8
7. M. Bennecke, L. Kriegl, M. Bajbouj, K. Retzlaff, S. Robine, A. Jung, and et al. Ink4a/Arf and oncogene-induced senescence prevent tumor progression during alternative colorectal tumorigenesis Cancer Cell 18 2010 135 146
8. N. Cancer Genome Atlas Comprehensive molecular characterization of human colon and rectal cancer Nature 487 2012 330 337
9. C. Chen, Y. Xu, and Y. Song IGF-1 gene-modified muscle-derived stem cells are resistant to oxidative stress via enhanced activation of IGF-1R/PI3K/AKT signaling and secretion of VEGF Mol. Cell. Biochem. 386 2014 167 175
10. W. Chen, and W.H. Xu Wnt/beta-catenin signaling regulates Helicoverpa armigera pupal development by up-regulating c-Myc and AP-4 Insect Biochem. Mol. Biol. 53 2014 44 53
11. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat. Rev. Genet. 10 2009 704 714
12. S. Dahan, G. Roda, D. Pinn, F. Roth-Walter, O. Kamalu, A.P. Martin, and et al. Epithelial: lamina propria lymphocyte interactions promote epithelial cell differentiation Gastroenterology 134 2008 192 203
13. C. Desbois-Mouthon, A. Cadoret, M.J. Blivet-Van Eggelpoel, F. Bertrand, G. Cherqui, C. Perret, and et al. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation Oncogene 20 2001 252 259
14. D. Fang, D. Hawke, Y. Zheng, Y. Xia, J. Meisenhelder, H. Nika, and et al. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity J. Biol. Chem. 282 2007 11221 11229
15. F.R. Greten, L. Eckmann, T.F. Greten, J.M. Park, Z.W. Li, L.J. Egan, and et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer Cell 118 2004 285 296
16. A. Guezguez, F. Pare, Y.D. Benoit, N. Basora, and J.F. Beaulieu Modulation of stemness in a human normal intestinal epithelial crypt cell line by activation of the WNT signaling pathway Exp. Cell Res. 322 2014 355 364
17. H. Guo, X. Hu, S. Ge, G. Qian, and J. Zhang Regulation of RAP1B by miR-139 suppresses human colorectal carcinoma cell proliferation Int. J. Biochem. Cell Biol. 44 2012 1465 1472
18. Y. Guo, J. Harwalkar, D.W. Stacey, and M. Hitomi Destabilization of cyclin D1 message plays a critical role in cell cycle exit upon mitogen withdrawal Oncogene 24 2005 1032 1042
19. T.C. He, A.B. Sparks, C. Rago, H. Hermeking, L. Zawel, L.T. da Costa, and et al. Identification of c-MYC as a target of the APC pathway Science 281 1998 1509 1512
20. B.T. Hennessy, D.L. Smith, P.T. Ram, Y. Lu, and G.B. Mills Exploiting the PI3K/AKT pathway for cancer drug discovery Nat. Rev. Drug Discov. 4 2005 988 1004
21. F. Hlubek, T. Brabletz, J. Budczies, S. Pfeiffer, A. Jung, and T. Kirchner Heterogeneous expression of Wnt/beta-catenin target genes within colorectal cancer Int. J. Cancer J. Int. Cancer 121 2007 1941 1948
22. S.H. Itzkowitz, and X. Yio Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation Am. J. Physiol. Gastrointest. Liver Physiol. 287 2004 G7 G17
23. K. Krishnan, A.L. Steptoe, H.C. Martin, D.R. Pattabiraman, K. Nones, N. Waddell, and et al. miR-139-5p is a regulator of metastatic pathways in breast cancer RNA 19 2013 1767 1780
24. G. Lee, T. Goretsky, E. Managlia, R. Dirisina, A.P. Singh, J.B. Brown, and et al. Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis Gastroenterology 139 2010 869-81, 81 e1-9.
25. J. Ma, H. Sawai, Y. Matsuo, N. Ochi, A. Yasuda, H. Takahashi, and et al. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells J. Surg. Res. 160 2010 90 101
26. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
27. J.P. Medema, and L. Vermeulen Microenvironmental regulation of stem cells in intestinal homeostasis and cancer Nature 474 2011 318 326
28. J.R. Miller, and R.T. Moon Analysis of the signaling activities of localization mutants of beta-catenin during axis specification in Xenopus J. Cell Biol. 139 1997 229 243
29. R.T. Moon, A.D. Kohn, G.V. De Ferrari, and A. Kaykas WNT and beta-catenin signalling: diseases and therapies Nat. Rev. Genet. 5 2004 691 701
30. C. Neufert, C. Becker, and M.F. Neurath An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression Nat. Protoc. 2 2007 1998 2004
31. H.T. Nguyen, G. Dalmasso, L. Torkvist, J. Halfvarson, Y. Yan, H. Laroui, and et al. CD98 expression modulates intestinal homeostasis, inflammation, and colitis-associated cancer in mice J. Clin. Investig. 121 2011 1733 1747
32. M.R. O'Connell, B.L. Oakes, S.H. Sternberg, A. East-Seletsky, M. Kaplan, and J.A. Doudna Programmable RNA recognition and cleavage by CRISPR/Cas9 Nature 516 2014 263 266
33. I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice Gastroenterology 98 1990 694 702
34. S. Ormanns, J. Neumann, D. Horst, T. Kirchner, and A. Jung WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear beta-Catenin depend on active PI3K signaling Oncotarget 5 2014 2999 3011
35. J.R. Pekow, and J.H. Kwon MicroRNAs in inflammatory bowel disease Inflamm. Bowel Dis. 18 2012 187 193
36. M. Pennati, M. Folini, and N. Zaffaroni Targeting survivin in cancer therapy: fulfilled promises and open questions Carcinogenesis 28 2007 1133 1139
37. F. Radtke, and H. Clevers Self-renewal and cancer of the gut: two sides of a coin Science 307 2005 1904 1909
38. S. Rakoff-Nahoum, J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis Cell 118 2004 229 241
39. G. Rogler Chronic ulcerative colitis and colorectal cancer Cancer Lett. 345 2014 235 241
40. K. Shen, Q. Liang, K. Xu, D. Cui, L. Jiang, P. Yin, and et al. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor Biochem. Pharmacol. 84 2012 320 330
41. J. Sun, and T. Jin Both Wnt and mTOR signaling pathways are involved in insulin-stimulated proto-oncogene expression in intestinal cells Cell. Signal. 20 2008 219 229
42. J. Terzic, S. Grivennikov, E. Karin, and M. Karin Inflammation and colon cancer Gastroenterology 138 2010 2101-14 e5
43. O. Tetsu, and F. McCormick Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells Nature 398 1999 422 426
44. T. Watanabe, T. Konishi, J. Kishimoto, K. Kotake, T. Muto, K. Sugihara, and et al. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: a nationwide Japanese study Inflamm. Bowel Dis. 17 2011 802 808
45. C.C. Wong, C.M. Wong, E.K. Tung, S.L. Au, J.M. Lee, R.T. Poon, and et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2 Gastroenterology 140 2011 322 331
46. S. Wu, Z. Ye, X. Liu, Y. Zhao, Y. Xia, A. Steiner, and et al. Salmonella typhimurium infection increases p53 acetylation in intestinal epithelial cells Am. J. Physiol. Gastrointest. Liver Physiol. 298 2010 G784 G794
47. M.H. Zaki, P. Vogel, R.K. Malireddi, M. Body-Malapel, P.K. Anand, J. Bertin, and et al. The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis Cancer Cell 20 2011 649 660
48. A. Zhang, Y. Zheng, Z. Que, L. Zhang, S. Lin, and V. Le I.V. Astragaloside inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO J. Cancer Res. Clin. Oncol. 140 2014 1883 1890